Drugs / sodium levofolinate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06700603 | Nov 2024 → Dec 2025 overdue | malignant pancreatic neoplasm | Rui-hua Xu, MD, PhD | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium levofolinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06700603 ↗ |